Scribe Therapeutics Achieves Second Success Milestone for In Vivo Program in Collaboration with Eli Lilly and Company
Original source ↗  |  February 17, 2026 at 13:00 UTC  |  Finnhub - LLY

No analysis available.

Trade Ideas
Ticker Direction Speaker Thesis Time
LLY
NONE Finnhub News